Advertisement
IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. (IDYA) Stock Overview

Explore IDEAYA Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

IDYANASDAQ
HealthcareBiotechnology
$37.65
$1.48(4.09%)
U.S. Market opens in NaNh NaNm
Advertisement

IDEAYA Biosciences, Inc. (IDYA)

Meyka AI Score

Z

Key Financials

Market Cap3.6B
P/E Ratio-23.83
EPS (TTM)$-1.60
ROE-0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$35.09
3 Months$38.63
1 Year Target$37.23

IDYA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IDEAYA Biosciences, Inc. (IDYA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.47, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $37.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.83 and a market capitalization of 3.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.09%
5-Day Change
2.87%
1-Month Change
32.57%
3-Month Change
16.42%
6-Month Change
11.23%
Year-to-Date (YTD) Change
8.91%
1-Year Change
70.36%
3-Year Change
64.63%
5-Year Change
65.71%
All-Time (Max) Change
236.46%

Contact Information

650 443 6209
7000 Shoreline Court, South San Francisco, CA, 94080

Company Facts

1,310 Employees
IPO DateMay 23, 2019
CountryUS
Actively Trading

Frequently Asked Questions